Back to top
more

Vapotherm (VAPO)

(Delayed Data from OTC)

$1.25 USD

1.25
5,517

-0.01 (-0.51%)

Updated Apr 26, 2024 03:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Will Vapotherm Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Vapotherm

The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare

The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare

Vapotherm (VAPO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Manaswita Ghosh Dutta headshot

3 Stocks in Focus as Coronavirus Boosts Medical Oxygen Demand

Oxygen therapy has emerged as a necessity for COVID-19 patients.

Vapotherm (VAPO) in Focus: Stock Moves 6.2% Higher

Vapotherm (VAPO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Vapotherm (VAPO) Reports Q4 Loss, Tops Revenue Estimates

Vapotherm (VAPO) delivered earnings and revenue surprises of 16.67% and 6.64%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Will Vapotherm (VAPO) Report Negative Earnings Next Week? What You Should Know

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health's Selling Seasons Strong, Omnicare Arm Upsets

CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.

Hologic Posts Solid Preliminary Q1 Sales, Revises Buyback Plan

Hologic (HOLX) expects to generate robust Surgical and Diagnostics revenues in Q1, though softness in the divested Medical Aesthetics business remains a concern.

Thermo Fisher Hits New 52-Week High: What's Driving the Stock?

Thermo Fisher (TMO) is optimistic about maintaining its growth momentum on several recent developments.

Medtronic's Neurostimulator DBS System Receives CE Mark

Medtronic's (MDT) Percept PC neurostimulator DBS system, with BrainSense technology, receives the CE Mark, thus clearing the way for the treatment of various neurologic disorders in the EU.

Medtronic (MDT) Buys Stimgenics, To Present New Trial Results

Medtronic (MDT) acquires Stimgenics to integrate DTM therapy in its pain therapies segment. It will also present trial results favoring the therapy at the upcoming NANS meeting.

Neogen Expands in South America With Productos Acquisition

Neogen (NEOG) expands operations in South America by acquiring its food safety diagnostics distributor partner that operates in Argentina and Uruguay.

Here's Why You Should Hold on to Zimmer (ZBH) Stock for Now

Investors continue to be optimistic about Zimmer (ZBH) on its stellar segmental performance in Q3.

Here's Why You Should Buy Align Technology (ALGN) Stock Now

Investors continue to be optimistic about Align Technology (ALGN) on its stellar segmental performance in Q3.

Hill-Rom Hits New 52-Week High: What's Driving the Stock?

Hill-Rom (HRC) is optimistic about maintaining its growth momentum on several recent developments.

Amedisys Completes Asana Hospice Acquisition, Expands Network

Amedisys (AMED) closes Asana takeover to strengthen its hospice care network.

Zacks.com featured highlights include: ACM, K12, Vapotherm, Equity Commonwealth and Columbus McKinnon

Zacks.com featured highlights include: ACM, K12, Vapotherm, Equity Commonwealth and Columbus McKinnon

Shrabana Mukherjee headshot

New Analyst Coverage Puts Spotlight on These 5 Stocks

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.